创伤性脑损伤凝血表型的推导及其与预后的关联:全国多中心研究的聚类分析
本研究为多中心队列研究,回顾性分析日本神经创伤数据库数据,纳入头部简明损伤定级>2且其他部位简明损伤定级<3的成人孤立性创伤性脑损伤患者556例,中位GCS评分6分(四分位距4-9)。采用k-means聚类基于入院时PT-INR、APTT、纤维蛋白原和D-二聚体推导出5种凝血表型:A型(n=129)凝血值最接近正常;B型(n=323)轻度D-二聚体升高;C型(n=30)PT-INR延长,老年患者抗血栓药物使用频率高于年轻患者;D型(n=45)纤维蛋白原低、D-二聚体高、APTT延长,颅骨骨折发生率高;E型(n=29)纤维蛋白原低、D-二聚体极高,高能量创伤和颅骨骨折发生率高。多因素logistic回归显示,以A型为参照,B、C、D、E型与院内死亡的调整比值比分别为2.17(95%CI 1.22-3.86)、2.61(95%CI 1.01-6.72)、10.0(95%CI 4.00-25.2)和24.1(95%CI 7.12-81.3)。该研究提示这些凝血表型与院内死亡相关,但 appropriate 治疗策略尚未建立。
要点
- 基于入院PT-INR、APTT、纤维蛋白原、D-二聚体将孤立性创伤性脑损伤聚类为5种凝血表型,A型凝血值最接近正常。
- 以A型为参照,B型院内死亡调整OR 2.17(95%CI 1.22-3.86),C型2.61(95%CI 1.01-6.72)。
- D型(纤维蛋白原低、D-二聚体高、APTT延长)院内死亡调整OR 10.0(95%CI 4.00-25.2),颅骨骨折发生率高。
- E型(纤维蛋白原低、D-二聚体极高)院内死亡调整OR 24.1(95%CI 7.12-81.3),高能量创伤和颅骨骨折发生率高。
- C型PT-INR延长,老年患者抗血栓药物使用频率高于年轻患者;研究中位GCS评分6分(四分位距4-9)。
适用人群与场景
- 成人孤立性创伤性脑损伤患者,头部简明损伤定级>2且其他部位简明损伤定级<3,登记于日本神经创伤数据库。
诊断标准与关键阈值
- 采用k-means聚类基于入院时凝血指标(PT-INR、APTT、纤维蛋白原、D-二聚体)推导凝血表型。
研究设计与关键结果
- 多中心队列研究,回顾性分析日本神经创伤数据库,共纳入556例孤立性创伤性脑损伤成人患者,中位GCS评分6分(四分位距4-9)。
- 识别出5种凝血表型:A型(n=129)凝血值最接近正常;B型(n=323)轻度D-二聚体升高;C型(n=30)PT-INR延长,老年患者抗血栓药物使用频率高于年轻患者;D型(n=45)纤维蛋白原低、D-二聚体高、APTT延长,颅骨骨折发生率高;E型(n=29)纤维蛋白原低、D-二聚体极高,高能量创伤和颅骨骨折发生率高。
- 多因素logistic回归显示,以A型为参照,B、C、D、E型与院内死亡的调整OR分别为2.17(95%CI 1.22-3.86)、2.61(95%CI 1.01-6.72)、10.0(95%CI 4.00-25.2)、24.1(95%CI 7.12-81.3)。
证据类型、等级与局限
- 证据类型:多中心观察性队列研究(聚类分析)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 研究提示入院凝血指标聚类表型与孤立性创伤性脑损伤患者院内死亡相关,但 appropriate 治疗策略尚未建立,原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The pathogenesis and pathophysiology of traumatic coagulopathy during traumatic brain injury is not well understood, and the appropriate treatment strategy for this condition has not been established. This study aimed to evaluate the coagulation phenotypes and their effect on prognosis in patients with isolated traumatic brain injury.
METHODS: In this multicenter cohort study, we retrospectively analyzed data from the Japan Neurotrauma Data Bank. Adults with isolated traumatic brain injury (head abbreviated injury scale > 2; abbreviated injury scale of any other trauma < 3) who were registered in the Japan Neurotrauma Data Bank were included in this study. The primary outcome was the association of coagulation phenotypes with in-hospital mortality. Coagulation phenotypes were derived using k-means clustering with coagulation markers, including prothrombin time international normalized ratio (PT-INR), activated partial thromboplastin time (APTT), fibrinogen (FBG), and D-dimer (DD) on arrival at the hospital. Multivariable logistic regression analyses were conducted to calculate the adjusted odds ratios of coagulation phenotypes with their 95% confidence intervals (CIs) for in-hospital mortality.
RESULTS: In total, 556 patients were enrolled and five coagulation phenotypes were identified. The median (interquartile range) score for the Glasgow Coma Scale was 6 (4-9). Cluster A (n = 129) had the closest to normal coagulation values; cluster B (n = 323) had a mild high DD phenotype; cluster C (n = 30) had a prolonged PT-INR phenotype with a higher frequency of antithrombotic medication in elderly patients than in younger patients; cluster D (n = 45) had a low amount of FBG, high DD, and prolonged APTT phenotype with a high incidence of skull fracture; and cluster E (n = 29) had a low amount of FBG and extremely high DD phenotype with high energy trauma and a high incidence of skull fracture. In the multivariable logistic regression analysis, the association of clusters B, C, D, and E with in-hospital mortality yielded the corresponding adjusted odds ratios of 2.17 (95% CI 1.22-3.86), 2.61 (95% CI 1.01-6.72), 10.0 (95% CI 4.00-25.2), and 24.1 (95% CI 7.12-81.3), respectively, relative to cluster A.
CONCLUSIONS: This multicenter, observational study identified five different coagulation phenotypes of traumatic brain injury and showed associations of these phenotypes with in-hospital mortality.
参考来源
- Fujiwara G, Okada Y, Shiomi N, et al. Derivation of Coagulation Phenotypes and the Association with Prognosis in Traumatic Brain Injury: A Cluster Analysis of Nationwide Multicenter Study. Neurocrit Care. 2023. PMID: 36977962. doi:10.1007/s12028-023-01712-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。